A wireless patch for the monitoring of C-reactive protein in sweat

J Tu, J Min, Y Song, C Xu, J Li, J Moore… - Nature biomedical …, 2023 - nature.com
The quantification of protein biomarkers in blood at picomolar-level sensitivity requires
labour-intensive incubation and washing steps. Sensing proteins in sweat, which would …

Heart failure population health considerations.

J Patel - American Journal of Managed Care, 2021 - search.ebscohost.com
Abstract The United States has an increasing number of patients with heart failure (HF) who
experience significant disease burden as well as contribute to high economic healthcare …

Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review

H Clark, R Rana, J Gow, M Pearson… - Heart Failure …, 2021 - Springer
Heart failure with preserved ejection fraction (HFpEF) is problematic to treat, with guidelines
for HFpEF management concentrated on treating prevalent comorbidities. The aim of this …

A conceptual model of home-based cardiac rehabilitation exercise adherence in patients with chronic heart failure: a constructivist grounded theory study

Z Yang, L Sun, Y Sun, Y Dong… - Patient preference and …, 2023 - Taylor & Francis
Purpose This study aimed to explore a conceptual model of home-based cardiac
rehabilitation exercise adherence and reveal its internal behavioral logic. Patients and …

[HTML][HTML] Cost effectiveness of vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening heart failure event from a US …

A Alsumali, LM Djatche, A Briggs, R Liu, I Diakite… - …, 2021 - Springer
Objective Given the high economic burden of disease among adult patients with chronic
heart failure with reduced ejection fraction (HFrEF) following a worsening heart failure event …

Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: The VICTORIA echocardiographic substudy

B Pieske, E Pieske‐Kraigher, CSP Lam… - European Journal of …, 2023 - Wiley Online Library
Aim Vericiguat significantly reduced the primary composite outcome of heart failure (HF)
hospitalization or cardiovascular death in the VICTORIA trial. It is unknown if these outcome …

Comparative pharmacokinetics of seven bioactive components after oral administration of crude and processed Qixue Shuangbu Prescription in chronic heart failure …

L Chen, N Wei, Y Jiang, C Yuan, L Xu, J Li… - Journal of …, 2023 - Elsevier
Abstract Ethnopharmacological relevance Qixue Shuangbu Prescription (QSP) is a classical
traditional Chinese medicine prescription, which has widely used for the treatment of chronic …

[HTML][HTML] Using deep learning to identify high-risk patients with heart failure with reduced ejection fraction

Z Wang, X Chen, X Tan, L Yang… - Journal of health …, 2021 - ncbi.nlm.nih.gov
Background: Deep Learning (DL) has not been well-established as a method to identify high-
risk patients among patients with heart failure (HF). Objectives: This study aimed to use DL …

Cost‐utility analysis of add‐on dapagliflozin in heart failure with preserved or mildly reduced ejection fraction

Y Tang, H Sang - ESC Heart Failure, 2023 - Wiley Online Library
Aims The DELIVER study demonstrates a significant improvement in cardiovascular death
or hospitalization for heart failure among heart failure with mildly reduced ejection fraction …

[HTML][HTML] Budget impact analysis of vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening event

A Alsumali, D Lautsch, R Liu, D Patel, S Nanji… - Advances in …, 2021 - Springer
Introduction In the USA, patients with chronic heart failure (HF) with reduced ejection fraction
(HFrEF) following a worsening HF event (WHFE) have significantly increased healthcare …